Bausch Health Companies Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $10.9B+12.8% YoYTTM through 30 Jun 2026
Net Income -$1.1BTTM through 30 Jun 2026
Free Cash Flow $1.4BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 70.9% |
| EBITDA Margin | 18.9% |
| Operating Margin | -37.6% |
| Net Margin | -10.1% |
Returns
62.0%ROE
-4.4%ROA
-6.4%ROIC
Balance Sheet Health
Debt / Equity-19.19x
Current Ratio1.44x
Net Debt$19.5B
Cash & Equivalents$1.8B
Quality Metrics
Altman Z-Score0.09
Piotroski F-Score5 / 9
FCF Margin13.2%
Rule of 4013.5
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $10.3B
Diluted EPS-$2.94TTMFY2025: $0.42
Dividend
No dividend
Capital Allocation
Capex Intensity3.4%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.